ANEB logo

Anebulo Pharmaceuticals (ANEB)

Profile

Full Name

Anebulo Pharmaceuticals, Inc.

Ticker Symbol

ANEB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 7, 2021

Indexes

Not included

Website

http://www.anebulo.com

Employees

2

Key Details

Price

$0.95(-2.56%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.32(+31.91% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.95
ANEB price is $0.95

30-Day Relative Volume

0.32
ANEB 30-day relative volume is 0.32

Price Performance

Price Most recent change

-2.56%
ANEB price was down -2.56% on Apr 14, 2025

Price YTD change

-43.45%
ANEB price is down -43.45% since January 1st

Price 1-year change

-67.89%
ANEB price is down -67.89% year-on-year

Price 3-year change

-82.6%
ANEB price is down -82.6% over the past 3 years

Price Range

Price All-time high

$9.33
ANEB price is currently -89.82% below its historical high of $9.33

Price 3-year low

$0.80
ANEB price is currently +18.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$39.03M
ANEB market capitalization is $39.03 million

Market cap 3-year change

-69.38%
ANEB market capitalization is down -69.38% over the past 3 years

Market cap All-time high

$208.23M
ANEB market capitalization is currently -81.26% below its historical high of $208.23 million

Market cap sector rank

34.79%
ANEB market capitalization is higher than 34.79% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+58.43%
ANEB shares outstanding is up +58.43% year-on-year

Shares Outstanding 3-Year Change

+75.99%
ANEB shares outstanding is up +75.99% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.44
ANEB beta is 0.44

200-day SMA

$1.73
ANEB price is currently -45.01% below its 200-day simple moving average

50-day SMA

$1.34
ANEB price is currently -28.93% below its 50-day simple moving average

RSI

33.84
ANEB 14-day relative strength index is 33.84

Volume

0.32
ANEB 30-day relative volume is 0.32

ATR

$0.18
ANEB average true range is $0.18

10-day Historical Volatility

50.89%
ANEB 10-day historical volatility is 50.89%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ANEB annual revenue value is unknown

Revenue Analysts estimate

-
ANEB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ANEB annual revenue 1-year change is unknown

Revenue Sector rank

-
ANEB annual revenue is unknown

EPS

EPS

-$0.32
ANEB annual earnings per share is -$0.32

EPS Analysts estimate

-$0.26
ANEB annual earnings per share is currently +23.08% higher than the consensus analysts' forecast

EPS 1-year change

+31.91%
ANEB annual earnings per share is up +31.91% year-on-year

EPS Sector rank

73.95%
ANEB annual earnings per share is higher than 73.95% of companies in Healthcare sector

Profit

Gross profit

-
ANEB annual gross profit value is unknown

Gross margin

-
ANEB annual gross profit margin value is unknown

Operating profit

-$8.31M
ANEB annual operating income is -$8.31 million

Operating margin

-
ANEB annual operating profit margin value is unknown

Net income

-$8.20M
ANEB annual net profit is -$8.20 million

Net margin

-
ANEB annual net profit margin value is unknown

Expenses

Total expenses

$8.31M
ANEB annual total expenses is $8.31 million

Operating expenses

$8.31M
ANEB annual total operating expenses is $8.31 million

Cost of goods sold

-
ANEB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.76M
ANEB annual SGA is $4.76 million

Depreciation and amortization

-
ANEB annual depreciation & amortization value is unknown

Interest expense

$151.20K
ANEB annual interest expense is $151.20 thousand

Income tax

-
ANEB annual income tax value is unknown

EBIT & EBITDA

EBIT

-$8.05M
ANEB annual earnings before interest & taxes is -$8.05 million

EBITDA

-$8.05M
ANEB annual EBITDA is -$8.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.07M
ANEB annual total assets is $4.07 million

Non current assets

$565.10K
ANEB annual long term assets is $565.10 thousand

Current assets

$3.51M
ANEB annual total current assets is $3.51 million

Cash and cash equivalents

$3.09M
ANEB annual cash & cash equivalents is $3.09 million

Accounts receivable

-
ANEB annual accounts receivable value is unknown

Inventory

-
ANEB annual inventory value is unknown

Liabilities

Total liabilities

$260.60K
ANEB annual total liabilities is $260.60 thousand

Long term liabilities

$0.00
ANEB annual total long term liabilities is $0.00

Current liabilities

$260.60K
ANEB annual total current liabilities is $260.60 thousand

Accounts payable

$156.40K
ANEB annual accounts payable is $156.40 thousand

Debt

Total debt

$0.00
ANEB annual total debt is $0.00

Total debt 1-year change

0%
ANEB {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
ANEB annual long term debt value is unknown

Short term debt

-
ANEB annual short term debt value is unknown

Equity & Capital

Shareholders equity

$3.81M
ANEB annual stockholders equity is $3.81 million

Book value

$3.81M
ANEB annual book value is $3.81 million

Retained earnings

-$65.40M
ANEB annual retained earnings is -$65.40 million

Working capital

$3.25M
ANEB annual working capital is $3.25 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$8.09M
ANEB annual cash flow from operations is -$8.09 million

Cash from operations 1-year change

+16.44%
ANEB annual cash flow from operations is up +16.44% year-on-year

Cash from investing

-
ANEB annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
ANEB annual cash flow from investing activities 1-year change is unknown

Cash from financing

-$62.40K
ANEB annual cash flow from financing activities is -$62.40 thousand

Cash from financing 1-year change

-100.98%
ANEB annual cash flow from financing activities is down -100.98% year-on-year

CAPEX

CAPEX

-
ANEB annual capital expenditures value is unknown

CAPEX 1-year change

-
ANEB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$8.09M
ANEB annual free cash flow is -$8.09 million

Free cash flow 1-year change

+16.44%
ANEB annual free cash flow is up +16.44% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ANEB annual gross profit margin value is unknown

Operating margin

-
ANEB annual operating profit margin value is unknown

Net margin

-
ANEB annual net profit margin value is unknown

ROA & ROE

ROA

-201.36%
ANEB annual return on assets is -201.36%

ROE

-215.13%
ANEB annual return on equity is -215.13%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ANEB price to earnings ratio value is unknown

PE ratio Sector rank

-
ANEB price to earnings ratio is unknown

PB Ratio

PB ratio

2.61
ANEB price to book ratio is 2.61

PB ratio Sector rank

69.88%
ANEB price to book ratio is higher than 69.88% of companies in Healthcare sector

PS Ratio

PS ratio

-
ANEB price to sales ratio value is unknown

PS ratio Sector rank

-
ANEB price to sales ratio is unknown

Enterprise value

Enterprise value

$24.03M
ANEB enterprise value is $24.03 million

Enterprise value Sector rank

33.97%
ANEB enterprise value is higher than 33.97% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.24
ANEB EV/EBITDA is -3.24

EV/EBITDA Sector rank

24.61%
ANEB EV/EBITDA is higher than 24.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

13.46
ANEB annual current ratio is 13.46

Quick ratio

-
ANEB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ANEB annual debt to equity ratio is 0.00

Interest coverage ratio

-53.24
ANEB annual interest coverage ratio is -53.24

Risk & Stability

Piotroski F-Score

-
ANEB piotroski f-score value is unknown

Altman Z-Score

-
ANEB altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 19, 24 Benchmark
Speculative Buy
Oct 1, 24 Benchmark
Speculative Buy
Oct 3, 23 Benchmark
Speculative Buy
Sep 25, 23 HC Wainwright & Co.
Buy
Sep 21, 23 Maxim Group
Buy
Sep 18, 23 HC Wainwright & Co.
Buy
May 18, 23 Benchmark
Speculative Buy
Feb 14, 23 Benchmark
Speculative Buy
Jul 27, 22 Ladenburg Thalmann
Buy
May 25, 21 Benchmark
Buy

Institutional Ownership

Similar stocks

ITRM logo
Iterum Therapeutics (ITRM)
SPRO logo
Spero Therapeutics (SPRO)
DXR logo
Daxor (DXR)
Pheton Holdings Ltd Class A (PTHL)
NVNO logo
enVVeno Medical (NVNO)
Opus Genetics (IRD)
ANTX logo
AN2 Therapeutics (ANTX)
RPTX logo
Repare Therapeutics (RPTX)
SCYX logo
SCYNEXIS (SCYX)
  • What is the ticker symbol for Anebulo Pharmaceuticals?
  • Does Anebulo Pharmaceuticals pay dividends?
  • What sector is Anebulo Pharmaceuticals in?
  • What industry is Anebulo Pharmaceuticals in?
  • What country is Anebulo Pharmaceuticals based in?
  • When did Anebulo Pharmaceuticals go public?
  • Is Anebulo Pharmaceuticals in the S&P 500?
  • Is Anebulo Pharmaceuticals in the NASDAQ 100?
  • Is Anebulo Pharmaceuticals in the Dow Jones?
  • When was Anebulo Pharmaceuticals's last earnings report?
  • When does Anebulo Pharmaceuticals report earnings?
  • Should I buy Anebulo Pharmaceuticals stock now?

What is the ticker symbol for Anebulo Pharmaceuticals?

The ticker symbol for Anebulo Pharmaceuticals is NASDAQ:ANEB

Does Anebulo Pharmaceuticals pay dividends?

No, Anebulo Pharmaceuticals does not pay dividends

What sector is Anebulo Pharmaceuticals in?

Anebulo Pharmaceuticals is in the Healthcare sector

What industry is Anebulo Pharmaceuticals in?

Anebulo Pharmaceuticals is in the Biotechnology industry

What country is Anebulo Pharmaceuticals based in?

Anebulo Pharmaceuticals is headquartered in United States

When did Anebulo Pharmaceuticals go public?

Anebulo Pharmaceuticals's initial public offering (IPO) was on May 7, 2021

Is Anebulo Pharmaceuticals in the S&P 500?

No, Anebulo Pharmaceuticals is not included in the S&P 500 index

Is Anebulo Pharmaceuticals in the NASDAQ 100?

No, Anebulo Pharmaceuticals is not included in the NASDAQ 100 index

Is Anebulo Pharmaceuticals in the Dow Jones?

No, Anebulo Pharmaceuticals is not included in the Dow Jones index

When was Anebulo Pharmaceuticals's last earnings report?

Anebulo Pharmaceuticals's most recent earnings report was on Feb 14, 2025

When does Anebulo Pharmaceuticals report earnings?

The next expected earnings date for Anebulo Pharmaceuticals is May 15, 2025

Should I buy Anebulo Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page